Sun Pharmaceutical Industries Limited has informed the Exchange regarding Completion and Results of Postal Ballot dated 17 March 2026
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharma has announced the completion of a postal ballot process through which shareholders approved three resolutions. First, shareholders ratified the remuneration of the Cost Auditor for FY 2025-26. Second, they approved alterations to Clause III(A) of the Memorandum of Association related to the company's Main Objects. Third, Dr. Pawan Goenka has been re-appointed as an Independent Director for a second five-year term, effective from 21 May 2026. The resolutions were passed with the requisite majority based on the Scrutinizer's Report.
Routine governance matters with no direct impact on stock price. The director re-appointment provides board continuity, while the MOA alteration may signal future business scope expansion.